Home Nucleus Medical Devices U.K. Acute Myeloid Leukemia Diagnostics Market to 2032

U.K. Acute Myeloid Leukemia Diagnostics Market to 2032

Overview

The U.K. Acute Myeloid Leukemia Diagnostics Market is expected to reach a 389.19 USD Million by 2032 and is projected to grow at a CAGR of 16.19% from 2025 to 2032.

Revenue, 2024 (USD Million)
167.52
Forecast, 2032 (USD Million)
389.19
CAGR, 2024 - 2032
16.19%
Report Coverage
U.K.

U.K. Acute Myeloid Leukemia Diagnostics Market 2018-2032 USD Million

U.K. Acute Myeloid Leukemia Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 167.52 USD Million
  • Projected Market Size (2032): 389.19 USD Million
  • CAGR (2025-2032): 16.19%

Key Findings of U.K. Acute Myeloid Leukemia Diagnostics Market

  • The U.K. Acute Myeloid Leukemia Diagnostics Market was valued at 167.52 USD Million in 2024.
  • The U.K. Acute Myeloid Leukemia Diagnostics Market is likely to grow at a CAGR of 16.19% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment 65 and Above in Age Group Segment accounted for the largest share of the market with a revenue of 124.77 USD Million
  • The fastest growing segment Myeloblastic (M0) in Cancer Segment grew Fastest with a CAGR of 22.41% during the forecast period from 2024 to 2032.

U.K. Acute Myeloid Leukemia Diagnostics Market Scope

U.K. Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospitals
Cancer
  • Megakaryocytic (M7)
  • Erythroleukemia (M6)
  • Monocytic (M5)
  • Myelomonocytic (M4)
  • Promyelocytic (M3)
  • Myeloblastic (M2)
  • Myeloblastic (M1)
  • Myeloblastic (M0)
Age Group
  • 21-29
  • Below 21
  • 30-65
  • 65 and Above
Gender
  • Female
  • Male
Product
  • Consumables & Accessories
  • Instruments
Test
  • Others
  • Immunophenotyping
  • Biomarker Test
  • Genetic Tests
  • Bone Marrow Tests
  • Imaging Test
  • Blood Test

U.K. Acute Myeloid Leukemia Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 167.52 USD Million
Market Value in 2032 389.19 USD Million
CAGR (2025-2032) 16.19%
Historic Data 2016-2023
Market Segments Covered Distribution Channel,End User,Cancer,Age Group,Gender,Product,Test

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 167.52 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 167.52 USD Million in 2024.

Segments and Scope

  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 114.40 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 18.02 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 60.63 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 20.40 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Cancer
    • Myeloblastic (M0) is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 50.88 USD Million in the year 2024.
    • Myeloblastic (M0) is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 22.41 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Age Group
    • 65 and Above is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 124.77 USD Million in the year 2024.
    • 65 and Above is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 17.15 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Gender
    • Male is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 97.84 USD Million in the year 2024.
    • Male is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 18.12 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Product
    • Instruments is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 109.64 USD Million in the year 2024.
    • Instruments is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 17.30 % in forecast period 2025-2032.
  • U.K. Acute Myeloid Leukemia Diagnostics Market to 2032, By Test
    • Blood Test is the largest segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 53.50 USD Million in the year 2024.
    • Blood Test is the Fastest growing segment in U.K. Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 20.46 % in forecast period 2025-2032.

U.K. Acute Myeloid Leukemia Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Myriad Genetics, Inc.
Sysmex Corporation
QIAGEN
BIOMÉRIEUX
CANON MEDICAL SYSTEMS CORPORATION
U.K. Acute Myeloid Leukemia Diagnostics Market Company Share Analysis

U.K. Acute Myeloid Leukemia Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Acute Myeloid Leukemia Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Acute Myeloid Leukemia Diagnostics Market Company Profiling

U.K. Acute Myeloid Leukemia Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Age Group,Gender,Product,Test.
U.K. Acute Myeloid Leukemia Diagnostics Market was valued at USD 167.52(Revenue in USD Million) in 2021.
U.K. Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.19% during the forecast period of 2024 to 2032.
The 65 and Above segment is expected to dominate the U.K. Acute Myeloid Leukemia Diagnostics Market, holding a largest market share of 124.77 USD Million in 2024

U.K. Acute Myeloid Leukemia Diagnostics Market Scope

U.K. Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospitals
Cancer
  • Megakaryocytic (M7)
  • Erythroleukemia (M6)
  • Monocytic (M5)
  • Myelomonocytic (M4)
  • Promyelocytic (M3)
  • Myeloblastic (M2)
  • Myeloblastic (M1)
  • Myeloblastic (M0)
Age Group
  • 21-29
  • Below 21
  • 30-65
  • 65 and Above
Gender
  • Female
  • Male
Product
  • Consumables & Accessories
  • Instruments
Test
  • Others
  • Immunophenotyping
  • Biomarker Test
  • Genetic Tests
  • Bone Marrow Tests
  • Imaging Test
  • Blood Test
Frequently Asked Questions
The U.K. Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Age Group,Gender,Product,Test.
U.K. Acute Myeloid Leukemia Diagnostics Market was valued at USD 167.52(Revenue in USD Million) in 2021.
U.K. Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.19% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Acute Myeloid Leukemia Diagnostics Market for final year is USD 389.19 (USD Million).

U.K. Acute Myeloid Leukemia Diagnostics Market Company Profiling

U.K. Acute Myeloid Leukemia Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Distribution Channel,End User,Cancer,Age Group,Gender,Product,Test.
U.K. Acute Myeloid Leukemia Diagnostics Market was valued at USD 167.52(Revenue in USD Million) in 2021.
U.K. Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 16.19% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Acute Myeloid Leukemia Diagnostics Market for final year is USD 389.19 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES